Literature DB >> 6212756

The cis-specificity of the Q-gene product of bacteriophage lambda.

D W Burt, W J Brammar.   

Abstract

A trp/lacW205 substitution, fused to the late region of bacteriophage lambda, provided a convenient assay for phage late gene expression in the presence or absence of lambda pQ. Comparison of lacZ expression from Q+ and Q- phages showed that late gene expression was markedly Q-dependent (263-fold difference). A cis/trans comparison of lambda pQ action showed a 180-fold difference in lacZ expression. The results suggest that pQ in only significantly active when supplied in cis to its site of action.

Entities:  

Mesh:

Year:  1982        PMID: 6212756     DOI: 10.1007/bf00334142

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  24 in total

Review 1.  A comprehensive molecular map of bacteriophage lambda.

Authors:  E H Szybalski; W Szybalski
Journal:  Gene       Date:  1979-11       Impact factor: 3.688

2.  On the nature of cis-acting regulatory proteins and genetic organization in bacteriophage: the example of gene Q of bacteriophage lambda.

Authors:  H Echols; D Court; L Green
Journal:  Genetics       Date:  1976-05       Impact factor: 4.562

3.  Control of late messenger RNA synthesis during lambda phage development.

Authors:  Y Takeda
Journal:  Biochim Biophys Acta       Date:  1971-01-01

4.  Genetic control of transcription during development of phage gamma.

Authors:  A Skalka; B Butler; H Echols
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

5.  Regulation of transcription of the lambda bacteriophage genome.

Authors:  K I Oda; Y Sakakibara; J I Tomizawa
Journal:  Virology       Date:  1969-12       Impact factor: 3.616

6.  Isolation and characterization of non-defective transducing elements of bacteriophage phi-80.

Authors:  S S Deeb; K Okamoto; B D Hall
Journal:  Virology       Date:  1967-02       Impact factor: 3.616

7.  Mutants of bacteriophage S13 blocked in infectious DNA synthesis.

Authors:  E S Tessman
Journal:  J Mol Biol       Date:  1966-05       Impact factor: 5.469

8.  Controls of rightward transcription in coliphage lambda.

Authors:  H J Nijkamp; K Bovre; W Szybalski
Journal:  J Mol Biol       Date:  1970-12-28       Impact factor: 5.469

9.  Characterization of lambdatrp-transducing bacteriophages made in vitro.

Authors:  A S Hopkins; N E Murray; W J Brammar
Journal:  J Mol Biol       Date:  1976-11-15       Impact factor: 5.469

10.  A minor Q-independent pathway for the expression of the late genes in bacteriophage lambda.

Authors:  C Dambly; M Couturier
Journal:  Mol Gen Genet       Date:  1971
View more
  6 in total

1.  Role of instability in the cis action of the insertion sequence IS903 transposase.

Authors:  K M Derbyshire; M Kramer; N D Grindley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Bacteriophage P22 gene 23 product acts preferentially in cis.

Authors:  P D Riggs; D Botstein
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

3.  Protein localization with flexible DNA or RNA.

Authors:  Sebastian Bernhardsson; Namiko Mitarai; Kim Sneppen
Journal:  PLoS One       Date:  2012-02-10       Impact factor: 3.240

4.  Hepatitis C virus RNA replication depends on specific cis- and trans-acting activities of viral nonstructural proteins.

Authors:  Teymur Kazakov; Feng Yang; Harish N Ramanathan; Andrew Kohlway; Michael S Diamond; Brett D Lindenbach
Journal:  PLoS Pathog       Date:  2015-04-13       Impact factor: 6.823

5.  Cell fate decisions emerge as phages cooperate or compete inside their host.

Authors:  Jimmy T Trinh; Tamás Székely; Qiuyan Shao; Gábor Balázsi; Lanying Zeng
Journal:  Nat Commun       Date:  2017-02-06       Impact factor: 14.919

6.  Prophage induction, but not production of phage particles, is required for lethal disease in a microbiome-replete murine model of enterohemorrhagic E. coli infection.

Authors:  Sowmya Balasubramanian; Marcia S Osburne; Haley BrinJones; Albert K Tai; John M Leong
Journal:  PLoS Pathog       Date:  2019-01-10       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.